Skip to main content

Table 2 Comparison of HER2 status with clinicopathological parameters of patients with UBC (n = 103)

From: Expression of human epidermal growth factor receptor 2 in bladder urothelial carcinoma

  HER2 protein overexpression NO. (%) of cases P-value
Absent Present
Age (median, interquartile range, years) 64 [55.5–74] 60 [59.5–70.5] 0.85
Sex
 Men 85 (82.5) 11 (10.7)  
 Women 6 (5.8) 1 (1) 0.59
Tumor size
 < 3 cm 40 (38.3) 3 (2.9)  
 ≥ 3 cm 51 (49.5) 9 (8.8) 0.21
Papillary architecture
 Absent 29 (28.2) 7 (6.8)  
 Present 62 (60.2) 5 (4.8) 0.1
Carcinoma in situ
 Absent 89 (86.4) 12 (11.6)  
 Present 2 (2%) 0 (0) 1
Tumor grade
 Low 65 (63.1) 3 (2.9)  
 High 26 (25.2) 9 (8.7) 0.003
Micropapillary differentiation
 Absent 89 (86.3) 11 (10.7)  
 Present 2 (2) 1 (1) 0.31
T stage
 ≤ pT1 76 (73.8) 6 (5.8)  
 >pT1 15 (14.6) 6 (5.8) 0.015
  1. Italic: Statistically significant at p <0.05
\